Upstream Cell Expansion

  1. SAFC Cell Culture Solutions 4/13/2021

    The SAFC® portfolio is a full-service provider for all your upstream process development and cGMP manufacturing needs. Discover all the  capabilities of our SAFC® cell culture solutions and which of our products are the perfect fit for your project.

  2. How To Fill And Empty Nunc Standard Cell Factory System 3/21/2022

    Watch this step by step how to instructional video to learn how to fill and empty the Thermo Scientific Nunc Standard Cell Factory System, which is compatible with the same cell culture techniques used in smaller cell culture vessels.

  3. MilliporeSigma Large Scale Capabilities Tour 10/20/2021

    A detailed look at MilliporeSigma’s new BioReliance® viral vector manufacturing facility and how we have employed the latest innovations and quality systems to deliver best-in-class gene therapy services.

  4. Cell Therapy Bioprocessing Workflow Cinematic 5/28/2025

    Witness a seamless cell therapy bioprocessing workflow that reduces manufacturing time and preserves the crucial cell phenotype for scalable, effective autologous and allogeneic therapies.

  5. How To Fill And Empty Nunc Standard Closed Cell Factory System 3/21/2022

    Watch this step by step how to instructional video to learn how to fill and empty the Nunc Standard Closed Cell Factory System, which is a closed system built with standard components to help ensure quality and assurance of supply.

  6. Optimize Your Cell Culture Feed Strategy With Cellvento® ModiFeed Prime COMP 4/1/2022

    This video shows how a new, easy-to-hydrate, single-part, pH neutral feed can support optimal cell growth and high productivity of CHO cell lines.

  7. Intensify Your Seed Train With The BioContinuum™ Seed Train Platform 7/13/2022

    Compatible with both fed-batch and perfusion N-production stages maximizing flexibility for end users, the BioContinuum™ Seed Train Platform enables you to unleash the full potential of seed train intensification.

  8. Multi-Specific Antibody Development: What Challenges The Need For Speed? 8/9/2023

    In this segment of the Bioprocess Online Live event, Process Development For A Diverse mAb Pipeline, Bayer’s Sr. Director, Bioprocess Technologies, Amir Goudarzi, Ph.D., addresses why the industry is pursuing faster, more cost-effective multi-specific antibody development and some of the major challenges standing in the way of efficiency.